NUP210L
Nuclear pore membrane glycoprotein 210-like
Also known as: P210L_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5VU65
- Gene
- NUP210L
- Ensembl
- ENSG00000143552
- Chromosome
- 1
- Canonical length
- 1888 aa
- Protein class
- Cancer-related genes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Nuclear bodies,Cytosol
OverviewNCBI Gene
Predicted to act upstream of or within Sertoli cell development and spermatid development. Predicted to be located in membrane. Predicted to be part of nuclear pore. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1888 residues, UniProt reviewed canonical sequence.
>Q5VU65|NUP210L
1 MTGCPASSRR RGFGLFFFLR LHRLLLLFLV LRGTLANKLN VPQVLLPFGR EPGRVPFLLE
61 AQRGCYTWHS THHDAVTVEP LYENGTLCSQ KAVLIAESTQ PIRLSSIILA REIVTDHELR
121 CDVKVDVINS IEIVSRAREL YVDDSPLELM VRALDAEGNT FSSLAGMMFE WSIAQDNESA
181 REELSSKIRI LKYSEAEYAP PIYIAEMEKE EKQGDVILVS GIRTGAAVVK VRIHEPFYKK
241 VAAALIRLLV LENIFLIPSH DIYLLVGTYI KYQVAKMVQG RVTEVKFPLE HYILELQDHR
301 VALNGSHSEK VAILDDKTAM VTASQLGQTN LVFVHKNVHM RSVSGLPNCT IYVVEPGFLG
361 FTVQPGNRWS LEVGQVYVIT VDVFDKSSTK VYISDNLRIT YDFPKEYFEE QLTTVNGSYH
421 IVKALKDGVV VINASLTSII YQNKDIQPIK FLIKHQQEVK IYFPIMLTPK FLAFPHHPMG
481 MLYRYKVQVE GGSGNFTWTS SNETVVIVTT KGVVTAGQVR GNSTVLARDV QNPFRYGEIK
541 IHVLKLNKME LLPFHADVEI GQIIEIPIAM YHINKETKEA MAFTDCSHLS LDLNMDKQGV
601 FTLLKEGIQR PGPMHCSSTH IAAKSLGHTL VTVSVNECDK YLESSATFAA YEPLKALNPV
661 EVALVTWQSV KEMVFEGGPR PWILEPSRFF LELNAEKTEK IGIAQVWLPS KRKQNQYIYR
721 IQCLDLGEQV LTFRIGNHPG VLNPSPAVEV LQVRFICAHP ASMSVTPVYK VPAGAQPCPL
781 PQHNKWLIPV SRLRDTVLEL AVFDQHRRKF DNFSSLMLEW KSSNETLAHF EDYKSVEMVA
841 KDDGSGQTRL HGHQILKVHQ IKGTVLIGVN FVGYSEKKSP KEISNLPRSV DVELLLVDDV
901 TVVPENATIY NHPDVKETFS LVEGSGYFLV NSSEQGVVTI TYMEAESSVE LVPLHPGFFT
961 LEVYDLCLAF LGPATAHLRV SDIQELELDL IDKVEIDKTV LVTVRVLGSS KRPFQNKYFR
1021 NMELKLQLAS AIVTLTPMEQ QDEYSENYIL RATTIGQTTL VAIAKDKMGR KYTSTPRHIE
1081 VFPPFRLLPE KMTLIPMNMM QVMSEGGPQP QSIVHFSISN QTVAVVNRRG QVTGKIVGTA
1141 VVHGTIQTVN EDTGKVIVFS QDEVQIEVVQ LRAVRILAAA TRLITATKMP VYVMGVTSTQ
1201 TPFSFSNANP GLTFHWSMSK RDVLDLVPRH SEVFLQLPVE HNFAMVVHTK AAGRTSIKVT
1261 VHCMNSSSGQ FEGNLLELSD EVQILVFEKL QLFYPECQPE QILMPINSQL KLHTNREGAA
1321 FVSSRVLKCF PNSSVIEEDG EGLLKAGSIA GTAVLEVTSI EPFGVNQTTI TGVQVAPVTY
1381 LRVSSQPKLY TAQGRTLSAF PLGMSLTFTV QFYNSIGEKF HTHNTQLYLA LNRDDLLHIG
1441 PGNKNYTYMA QAVNRGLTLV GLWDRRHPGM ADYIPVAVEH AIEPDTKLTF VGDIICFSTH
1501 LVSQHGEPGI WMISANNILQ TDIVTGVGVA RSPGTAMIFH DIPGVVKTYR EVVVNASSRL
1561 MLSYDLKTYL TNTLNSTVFK LFITTGRNGV NLKGFCTPNQ ALAITKVLLP ATLMLCHVQF
1621 SNTLLDIPAS KVFQVHSDFS MEKGVYVCII KVRPQSEELL QALSVADTSV YGWATLVSER
1681 SKNGMQRILI PFIPAFYINQ SELVLSHKQD IGEIRVLGVD RVLRKLEVIS SSPVLVVAGH
1741 SHSPLTPGLA IYSVRVVNFT SFQQMASPVF INISCVLTSQ SEAVVVRAMK DKLGADHCED
1801 SAILKRFTGS YQILLLTLFA VLASTASIFL AYNAFLNKIQ TVPVVYVPTL GTPQPGFFNS
1861 TSSPPHFMSL QPPLAQSRLQ HWLWSIRHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NUP210L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- testis: 25 nTPM
- choroid plexus: 0.6 nTPM
- retina: 0.4 nTPM
- pituitary gland: 0.3 nTPM
- seminal vesicle: 0.3 nTPM
- smooth muscle: 0.2 nTPM
Single-cell type
- early primary spermatocytes: 108 nCPM
- endometrial luminal cells: 83 nCPM
- differentiating spermatogonia: 56 nCPM
- late primary spermatocytes: 55 nCPM
- epididymal basal cells: 52 nCPM
- endometrial glandular cells: 49 nCPM
Immune cell
- neutrophil: 0.3 nTPM
- eosinophil: 0.2 nTPM
- naive CD4 T-cell: 0.1 nTPM
- NK-cell: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- T-reg: 0.1 nTPM
Brain region
- cerebellum: 7.4 nTPM
- white matter: 6.8 nTPM
- cerebral cortex: 4.3 nTPM
- pons: 4.1 nTPM
- basal ganglia: 3.9 nTPM
- medulla oblongata: 3.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NUP210L.
Disease | AllUniProt
Conditions NUP210L is implicated in, by any mechanism.
- Spermatogenic failure 97 (SPGF97) MIM:621057
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 210 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Spermatogenic failure 97
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.38
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.68
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Bacterial Ig-like domain, group 2
- Invasin/intimin cell-adhesion fragments
- Nuclear pore membrane glycoprotein 210-like
- NUP210, Ig-like domain 15
- NUP210, C-terminal Ig-like domain
- NUP210, Ig-like domain 1
- NUP210, Ig-like domain 2
- NUP210, Ig-like domain 3
- NUP210, Ig-like domain 7
- NUP210, fourth Ig-like domain
- NUP210, Ig-like domain 6
- NUP210, Ig-like domain 9
- NUP210, Ig-like domain 16
- NUP210, Ig-like domain 13
- Bacterial Ig-like domain (group 2)
- NUP210 Ig-like domain
- NUP210 Ig-like domain 15
- NUP210 Ig-like domain 7
- NUP210 Ig-like domain 3
- NUP210 Ig-like domain 1
- NUP210 Ig-like domain 2
- NUP210, Ig-like domain 9
- NUP210-like, Ig-like domain 6
- NUP210 forth Ig-like domain
- NUP210-like, Ig-like domain 16
- NUP210 Ig-like domain 13
- NUP210 Ig-like domain 5
- NUP210 Ig-like domain 14
- NUP210 Ig-like domain 8
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NUP210L as an antibody target. Whether an autoantibody or antibody against NUP210L could matter depends on whether native NUP210L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NUP210L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NUP210L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...